PerkinElmer (United States) (PKI) → Stock, financial statements

PerkinElmer (United States)

160.96 USD +4.57 (+2.55%)
Aug 11 🇺🇸 NYSE PKI
Dividends News
  • PKI Ticker
  • 🇺🇸 NYSE Exchange
  • 12,500 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — PerkinElmer (United States)

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
21 ← 17 2021 2019 2018 2017 2017
Total Revenue
3.8B 2.9B 2.8B 2.3B 2.1B
Cost Of Revenue
1.7B 1.5B 1.4B 1.2B 1.1B
Gross Profit
2.1B 1.4B 1.3B 1.1B 1B
Research and Development
210M 190M 190M 140M 120M
Selling General and Admin
920M 820M 810M 620M 600M
Operating Expense
2.8B 2.5B 2.4B 1.9B 1.8B
Operating Income
990M 390M 340M 320M 290M
Other Income Expense Net
0 0 0 0 0
990M 390M 340M 320M 290M
Interest Income
49M 62M 66M 41M 41M
Pretax Income
910M 240M 260M 300M 240M
Income Tax
180M 9.4M 20M 140M 28M
Minority Interest
0 0 0 0 0
Net Income
730M 230M 240M 290M 230M
Net Income Basic
730M 230M 240M 290M 230M
21 ← 17 2021 2019 2018 2017 2017
Current cash
400M 190M 160M 200M 360M
Short term investments
170M 100M 100M 94M 99M
1.2B 730M 630M 550M 430M
510M 360M 340M 350M 250M
Other current assets
170M 100M 100M 94M 99M
Current assets
2.2B 1.4B 1.2B 1.2B 1.2B
Long term investments
5.7B 5.2B 4.7B 4.9B 3.1B
Property plant equipment
370M 320M 320M 300M 150M
3.4B 3.1B 3B 3B 2.2B
Intangible assets
1.4B 1.3B 1.2B 1.3B 420M
Other assets
280M 250M 250M 230M 200M
Total assets
8B 6.5B 6B 6.1B 4.3B
Accounts payable
330M 240M 220M 220M 170M
Current long term debt
380M 10M 15M 220M 1.2M
Other current liabilities
940M 520M 540M 510M 430M
Total current liabilities
1.7B 760M 770M 950M 600M
Long term debt
1.6B 2.1B 1.9B 1.8B 1B
Other liabilities
770M 750M 740M 850M 460M
Minority Interest
0 0 0 0 0
Total Liabilities
4.2B 3.7B 3.4B 3.6B 2.1B
Common stock
110M 110M 110M 110M 110M
Retained earning
3.5B 2.8B 2.6B 2.4B 2.1B
Treasury stock
0 0 0 0 0
Capital surplus
Shareholder equity
3.7B 2.8B 2.6B 2.5B 2.2B
Net tangible assets
-1.1B -1.6B -1.6B -1.8B -510M
21 ← 17 2021 2019 2018 2017 2017
Net Income
730M 230M 240M 290M 230M
250M 210M 180M 110M 100M
Changes in receivables
430M 93M 80M 130M -13M
Changes in inventories
160M 19M -13M 100M -41M
Cash change
210M 29M -39M -160M 120M
Cash flow
890M 360M 310M 290M 350M
Capital expenditures
-78M -76M -93M -39M -32M
Investing activity other
Total investing cash flows
-500M -490M -160M -1.2B -100M
Dividends paid
Net borrowings
1.4B 1.8B 1.6B 1.7B 590M
Other financing cash flows
Cash flow financing
-200M 150M -180M 780M -120M
Exchange rate effect

PerkinElmer, Inc. engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following two segments: Discovery & Analytical Solutions, and Diagnostics. The Discovery & Analytical Solutions segment comprises of technologies that help life sciences researchers better understand diseases and develop treatments. The Diagnostics segment offers instruments, reagents, assay platforms, and software to hospitals, medical labs, clinicians, and medical research professionals to help improve the health of families. The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937 and is headquartered in Waltham, MA.